Email us for help
Loading...
Premium support
Log Out
Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.
At all stages of and levels of prostate cancer, whether you have low, intermediate, or high risk disease, whether you are newly diagnosed, have recurrent disease or your prostate cancer has advanced and metastasized, the same questions arise.
So, what does define 'value' for patients in the management of prostate cancer? CureTalk's prostate cancer panel of Mike Scott, Tony Crispino, Joel Nowak, Richard Davis, Paul Carpenter and Jan Manarite will be sharing their experiences and thoughts on this.
RSVP HERE!